Arie Perry, MD
Affiliations: | Pathology and Laboratory Medicine | University of California, San Francisco, San Francisco, CA |
Area:
neuro-oncologyWebsite:
http://labmed.ucsf.edu/about/faculty/pathology-aperry.htmlGoogle:
"Arie Perry"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Asa SL, Mete O, Riddle ND, et al. (2023) Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Endocrine Pathology |
| Asa SL, Mete O, Schüller U, et al. (2022) Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin. The American Journal of Surgical Pathology |
| Keck MK, Sill M, Wittmann A, et al. (2022) Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathologica |
| Lucas CG, Sloan EA, Gupta R, et al. (2022) Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica |
| Asa SL, Mete O, Perry A, et al. (2022) Overview of the 2022 WHO Classification of Pituitary Tumors. Endocrine Pathology. 33: 6-26 |
| Pratt D, Abdullaev Z, Papanicolau-Sengos A, et al. (2022) High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta Neuropathologica |
| Sloan EA, Gupta R, Koelsche C, et al. (2021) Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathology (Zurich, Switzerland). e13037 |
| Schmid S, Solomon DA, Perez E, et al. (2021) Genetic and epigenetic characterization of posterior pituitary tumors. Acta Neuropathologica |
| Louis DN, Perry A, Wesseling P, et al. (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology |
| Asa SL, Mete O, Cusimano MD, et al. (2021) Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |